内化β2-上腺素受体反对PLC依赖的高缩信号传递
1Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor.
Circulation research
|May 30, 2024
概括
β2-上腺素受体 (β2-AR) 激活通过抑制脂酶Cε信号传递来保护心脏免受缩. 这一途径涉及β2-AR内部化和Gi/Gβγ信号传递,为心力衰竭保护提供了一种新的机制.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 细胞信号传递 细胞信号传递
背景情况:
- 上腺体度升高通过β-上腺体受体 (β-AR) 过度刺激导致心力衰竭的进展.
- β1-AR和β2-AR亚型在心脏功能和缩中具有不同的,往往相反的作用.
- 虽然β1-AR激活是有害的,但心脏中β2-AR信号的保护机制尚未完全理解.
研究的目的:
- 阐明 β2-AR 信号传导对心脏缩的保护作用背后的分子机制.
- 研究β2-AR激活如何调节心脏肌细胞中的细胞内信号通路.
主要方法:
- 利用分离的新生小鼠心室肌细胞和成年小鼠心室肌细胞.
- 采用活细胞成像和西方抹黑技术.
- 研究了β2-AR信号在调节心脏缩中的作用.
主要成果:
- β2-AR激活抑制了脂酶Cε (PLCε) 的信号传递,特别是在戈尔吉装置.
- 这种抑制需要β2-AR内部化,Gi/Gβγ子单元在内分泌体的激活和ERK激活.
- 该途径降低蛋白激酶D (PKD) 和基因素脱乙酶5 (HDAC5) 酸化,防止心脏缩.
结论:
- 确定了一种新的机制,其中β2-AR对抗PLCε通路.
- 这种β2-AR信号通路抑制了血管激素II和Golgi局部化的β1-AR介导信号.
- 研究结果揭示了β2-AR信号在心力衰竭中的心脏保护作用的分子基础.
更多相关视频
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
2.8K
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.3K
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Antihypertensive Drugs: Action of β1 Blockers
427
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
427
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
